Coronary CTA exposes plaque risk for diabetics
Findings from a large multicenter study suggest 64-slice CT angiography is better suited than other cardiac diagnostic tests for detecting clinically relevant coronary artery plaques in patients with diabetes.
Findings from a large multicenter study suggest 64-slice CT angiography is better suited than other cardiac diagnostic tests for detecting clinically relevant coronary artery plaques in patients with diabetes.
Dr. Fay Y. Lin, an associate professor of medicine at Cornell University, and colleagues prospectively evaluated a cohort of 3926 patients with symptomatic cardiovascular disease, Lin determined that 727 had diabetes. All patients underwent coronary 64-slice CTA between 2005 and 2007. Researchers found that patients with diabetes faced twice the risk of dying from a cardiac-related problem within two years of diagnosis as nondiabetic patients. CTA more accurately characterized plaque burden than alternative modalities for patients with low calcium score or normal stress testing results. Lin reported the findings at the 2009 Society of Cardiovascular Computed Tomography meeting.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
